31 results
424B5
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Prospectus supplement for primary offering
5:16pm
has been observed to have a higher affinity for the soluble IL-6R from antibody binding studies conducted in cell culture. TZLS-501 also demonstrated
F-3/A
4qwtjx
25 Feb 22
Shelf registration (foreign) (amended)
4:10pm
F-3/A
dp135gl awqr5
1 Feb 22
Shelf registration (foreign) (amended)
4:15pm
F-3
b2pds9otw 3qk6ac
26 Jan 21
Shelf registration (foreign)
5:31pm
6-K
EX-99.1
kr3kq5xy9k8w7u
30 Sep 20
Interim Results for the Six Months Ended 30 June 2020
6:11am
424B5
gw0phw42xj8xz
4 Aug 20
Prospectus supplement for primary offering
4:35pm
6-K
EX-99.1
1b7cfm8
18 Jun 20
Final Results for the Year Ended 31 December 2019
7:01am
424B5
zmmrcexr 2v
10 Apr 20
Prospectus supplement for primary offering
5:22pm
424B5
7zgo2b2ur12qp8ccb
14 Feb 20
Prospectus supplement for primary offering
12:00am
F-3/A
prm8s3xd 2mh7
30 Jan 20
Shelf registration (foreign) (amended)
4:47pm
F-3
tru9p796clez7gw
22 Jan 20
Shelf registration (foreign)
4:31pm
6-K
EX-99.1
u9hirt4xz3
30 Sep 19
Interim Results for the Six Months Ended 30 June 2019
7:55am
F-1/A
xhqb 16zaf
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
puui ngnrixr5
17 Sep 19
Registration statement (foreign) (amended)
5:19pm